Editorial: measuring disease severity in inflammatory bowel disease-the whole is greater than the sum of its parts. Authors' reply

Akhilesh Swaminathan^{1

2}, Thomas C Mules², Richard B Gearry^{1

2}

Affiliations

¹ Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand.
² Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.

Editorial

Akhilesh Swaminathan et al. Aliment Pharmacol Ther. 2022 Aug.

. 2022 Aug;56(4):746-747.

doi: 10.1111/apt.17126.

Akhilesh Swaminathan^{1

2}, Thomas C Mules², Richard B Gearry^{1

2}

¹ Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand.
² Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.

No abstract available

Comment on

The disease severity index for inflammatory bowel disease is associated with psychological symptoms and quality of life, and predicts a more complicated disease course.
Swaminathan A, Fan D, Borichevsky GM, Mules TC, Hirschfeld E, Frampton CM, Day AS, Siegel CA, Gearry RB. Swaminathan A, et al. Aliment Pharmacol Ther. 2022 Aug;56(4):664-674. doi: 10.1111/apt.17058. Epub 2022 May 27. Aliment Pharmacol Ther. 2022. PMID: 35633043 Free PMC article.
Editorial: measuring disease severity in inflammatory bowel disease-the whole is greater than the sum of its parts.
Keefer L, Shapiro MJ. Keefer L, et al. Aliment Pharmacol Ther. 2022 Aug;56(4):744-745. doi: 10.1111/apt.17108. Aliment Pharmacol Ther. 2022. PMID: 35879896 No abstract available.

1. Keefer L, Shapiro M. Editorial: measuring disease severity in inflammatory bowel disease - the whole is greater than the sum of its parts. Aliment Pharmacol Ther. 2022;56:742-743.
1. Colombel JF, Panaccione R, Bossuyt P, Lukas M, Baert F, Vaňásek T, et al. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet. 2017;390:2779-89.
1. Turner D, Ricciuto A, Lewis A, D'Amico F, Dhaliwal J, Griffiths AM, et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology. 2021;160(5):1570-83.
1. Mules TC, Swaminathan A, Hirschfeld E, Borichevsky G, Frampton C, Day AS, et al. The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the stress, anxiety and depression with disease activity (SADD) study. Aliment Pharmacol Ther. 2022;55(2):201-11.
1. Williet N, Sandborn WJ, Peyrin-Biroulet L. Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12(8):1246-1256.e6.